Yasmeen Rahimi
Stock Analyst at Piper Sandler
(4.94)
# 165
Out of 4,966 analysts
796
Total ratings
49%
Success rate
35.2%
Average return
Main Sectors:
Stocks Rated by Yasmeen Rahimi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLYM Climb Bio | Reiterated: Buy | $23 → $40 | $14.25 | +180.70% | 6 | Sep 3, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $76 | $29.05 | +161.62% | 13 | Aug 31, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $14 | $1.86 | +652.69% | 6 | Aug 31, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | $40 | $40.82 | -2.01% | 6 | Aug 28, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $95 | $36.44 | +160.70% | 5 | Aug 27, 2026 | |
| SVRA Savara | Reiterated: Buy | $16 | $5.32 | +201.03% | 23 | Aug 26, 2026 | |
| AGMB AgomAb Therapeutics NV | Initiated Coverage: Buy | $60 | $13.06 | +359.42% | 1 | Aug 25, 2026 | |
| NKTR Nektar Therapeutics | Reiterated: Buy | $192 | $69.76 | +175.23% | 19 | Aug 20, 2026 | |
| ORKA Oruka Therapeutics | Reiterated: Buy | $180 | $91.14 | +97.50% | 7 | Aug 17, 2026 | |
| ALGS Aligos Therapeutics | Reiterated: Buy | $175 | $5.22 | +3,252.49% | 30 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 | $73.77 | +45.05% | 34 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 | $38.66 | +140.56% | 25 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 | $37.36 | +76.66% | 14 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $13.81 | +117.23% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.00 | +200.00% | 24 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,200 | $334.58 | +258.66% | 38 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $8.87 | +305.86% | 29 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $73 | $8.49 | +759.84% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $0.64 | +6,150.00% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $21.27 | +182.09% | 12 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 | $44.63 | +74.77% | 8 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 | $53.87 | +72.64% | 19 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $5.21 | +399.04% | 8 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.4298 | +1,528.66% | 19 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $2.11 | +847.87% | 1 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3 → $13 | $1.87 | +595.19% | 6 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $900 | $534.41 | +68.41% | 48 | Jun 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $5.70 | +1,215.79% | 12 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $4.02 | +546.77% | 5 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $5.29 | +1,601.32% | 5 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $14.63 | +36.71% | 15 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $93 → $220 | $63.18 | +248.21% | 4 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.17 | +156.41% | 25 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $48 → $60 | $16.12 | +272.21% | 9 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $2.06 | +1,113.59% | 3 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.20 | +141.94% | 2 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $10.73 | +39.79% | 21 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 → $25 | $14.73 | +69.72% | 35 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 | $44.40 | +14.86% | 15 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $12.23 | +145.30% | 11 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $3.27 | n/a | 36 | Jun 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $67 | $10.88 | n/a | 6 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $11.42 | n/a | 26 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $25 → $40 | $3.21 | n/a | 11 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $35 | $148.18 | n/a | 15 | Jul 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $87 | $12.68 | n/a | 11 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $77 | $98.22 | n/a | 13 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $13.80 | n/a | 29 | Mar 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $0.485 | n/a | 5 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $1.78 | n/a | 1 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.9 | $0.185 | n/a | 4 | Sep 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $143.97 | n/a | 7 | Jun 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $4 | $0.706 | n/a | 2 | May 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $6 | $0.8117 | n/a | 2 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $0.0706 | n/a | 1 | Mar 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €70.00 | €13.02 | n/a | 1 | Dec 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $12 | $0.0077 | n/a | 2 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.92 | n/a | 2 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $0.0001 | n/a | 2 | Aug 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $2 | $1.66 | n/a | 3 | Aug 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $29 | $27.01 | n/a | 1 | Jul 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $8 | $3.91 | n/a | 4 | Jan 4, 2018 |
Climb Bio
Sep 3, 2026
Reiterated: Buy
Price Target: $23 → $40
Current: $14.25
Upside: +180.70%
Tectonic Therapeutic
Aug 31, 2026
Reiterated: Buy
Price Target: $76
Current: $29.05
Upside: +161.62%
Tenax Therapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $14
Current: $1.86
Upside: +652.69%
Roivant Sciences
Aug 28, 2026
Reiterated: Buy
Price Target: $40
Current: $40.82
Upside: -2.01%
First Tracks Biotherapeutics
Aug 27, 2026
Reiterated: Buy
Price Target: $95
Current: $36.44
Upside: +160.70%
Savara
Aug 26, 2026
Reiterated: Buy
Price Target: $16
Current: $5.32
Upside: +201.03%
AgomAb Therapeutics NV
Aug 25, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $13.06
Upside: +359.42%
Nektar Therapeutics
Aug 20, 2026
Reiterated: Buy
Price Target: $192
Current: $69.76
Upside: +175.23%
Oruka Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $180
Current: $91.14
Upside: +97.50%
Aligos Therapeutics
Aug 7, 2026
Reiterated: Buy
Price Target: $175
Current: $5.22
Upside: +3,252.49%
Aug 7, 2026
Reiterated: Buy
Price Target: $107
Current: $73.77
Upside: +45.05%
Aug 7, 2026
Reiterated: Buy
Price Target: $93
Current: $38.66
Upside: +140.56%
Aug 7, 2026
Reiterated: Buy
Price Target: $66
Current: $37.36
Upside: +76.66%
Aug 7, 2026
Reiterated: Buy
Price Target: $30
Current: $13.81
Upside: +117.23%
Aug 7, 2026
Reiterated: Buy
Price Target: $6
Current: $2.00
Upside: +200.00%
Aug 7, 2026
Reiterated: Buy
Price Target: $1,200
Current: $334.58
Upside: +258.66%
Aug 7, 2026
Reiterated: Buy
Price Target: $36
Current: $8.87
Upside: +305.86%
Aug 6, 2026
Rated: Buy
Price Target: $73
Current: $8.49
Upside: +759.84%
Aug 6, 2026
Reiterated: Buy
Price Target: $40
Current: $0.64
Upside: +6,150.00%
Aug 4, 2026
Reiterated: Buy
Price Target: $60
Current: $21.27
Upside: +182.09%
Aug 3, 2026
Reiterated: Buy
Price Target: $78
Current: $44.63
Upside: +74.77%
Jul 21, 2026
Reiterated: Buy
Price Target: $93
Current: $53.87
Upside: +72.64%
Jul 17, 2026
Reiterated: Buy
Price Target: $26
Current: $5.21
Upside: +399.04%
Jul 16, 2026
Reiterated: Buy
Price Target: $7
Current: $0.4298
Upside: +1,528.66%
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $2.11
Upside: +847.87%
Jul 8, 2026
Upgraded: Buy
Price Target: $3 → $13
Current: $1.87
Upside: +595.19%
Jun 29, 2026
Reiterated: Buy
Price Target: $900
Current: $534.41
Upside: +68.41%
Jun 25, 2026
Reiterated: Buy
Price Target: $75
Current: $5.70
Upside: +1,215.79%
Jun 8, 2026
Reiterated: Buy
Price Target: $26
Current: $4.02
Upside: +546.77%
Jun 1, 2026
Reiterated: Buy
Price Target: $90
Current: $5.29
Upside: +1,601.32%
May 27, 2026
Reiterated: Buy
Price Target: $20
Current: $14.63
Upside: +36.71%
May 20, 2026
Rated: Buy
Price Target: $93 → $220
Current: $63.18
Upside: +248.21%
May 12, 2026
Reiterated: Buy
Price Target: $3
Current: $1.17
Upside: +156.41%
May 11, 2026
Rated: Buy
Price Target: $48 → $60
Current: $16.12
Upside: +272.21%
Apr 13, 2026
Reiterated: Buy
Price Target: $25
Current: $2.06
Upside: +1,113.59%
Apr 13, 2026
Reiterated: Buy
Price Target: $15
Current: $6.20
Upside: +141.94%
Mar 18, 2026
Reiterated: Buy
Price Target: $15
Current: $10.73
Upside: +39.79%
Mar 4, 2026
Reiterated: Buy
Price Target: $72 → $25
Current: $14.73
Upside: +69.72%
Feb 9, 2026
Reiterated: Buy
Price Target: $51
Current: $44.40
Upside: +14.86%
Sep 24, 2025
Reiterated: Buy
Price Target: $30
Current: $12.23
Upside: +145.30%
Jun 27, 2025
Reiterated: Buy
Price Target: $25
Current: $3.27
Upside: n/a
Jun 17, 2025
Reiterated: Buy
Price Target: $67
Current: $10.88
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $28
Current: $11.42
Upside: n/a
Dec 14, 2023
Downgraded: Hold
Price Target: $25 → $40
Current: $3.21
Upside: n/a
Jul 5, 2023
Rated: Buy
Price Target: $35
Current: $148.18
Upside: n/a
May 9, 2023
Rated: Buy
Price Target: $87
Current: $12.68
Upside: n/a
May 8, 2023
Rated: Buy
Price Target: $77
Current: $98.22
Upside: n/a
Mar 15, 2022
Reiterated: Buy
Price Target: $19
Current: $13.80
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $18
Current: $0.485
Upside: n/a
Oct 12, 2021
Upgraded: Hold
Price Target: n/a
Current: $1.78
Upside: n/a
Sep 13, 2021
Reiterated: Hold
Price Target: $0.9
Current: $0.185
Upside: n/a
Jun 3, 2020
Reiterated: Buy
Price Target: $68
Current: $143.97
Upside: n/a
May 15, 2020
Reiterated: Buy
Price Target: $6 → $4
Current: $0.706
Upside: n/a
May 8, 2020
Reiterated: Buy
Price Target: $35 → $6
Current: $0.8117
Upside: n/a
Mar 20, 2020
Reiterated: Buy
Price Target: $9
Current: $0.0706
Upside: n/a
Dec 19, 2019
Reiterated: Buy
Price Target: €70.00
Current: €13.02
Upside: n/a
Dec 18, 2019
Reiterated: Buy
Price Target: $15 → $12
Current: $0.0077
Upside: n/a
Sep 6, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.92
Upside: n/a
Aug 2, 2019
Reiterated: Buy
Price Target: $8
Current: $0.0001
Upside: n/a
Aug 10, 2018
Downgraded: Hold
Price Target: $30 → $2
Current: $1.66
Upside: n/a
Jul 24, 2018
Initiated Coverage: Buy
Price Target: $29
Current: $27.01
Upside: n/a
Jan 4, 2018
Reiterated: Buy
Price Target: $3 → $8
Current: $3.91
Upside: n/a